197 related articles for article (PubMed ID: 8416740)
1. Overexpression of basic fibroblast growth factor complementary DNA in Ha-ras-transformed cells correlates with a decreased incidence of tumor necrosis.
Peretz D; Kimel N; Fujii DK; Neufeld G
Cancer Res; 1993 Jan; 53(1):158-64. PubMed ID: 8416740
[TBL] [Abstract][Full Text] [Related]
2. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of human fibroblasts by a transfected N-ras oncogene.
Wilson DM; Yang DJ; Dillberger JE; Dietrich SE; Maher VM; McCormick JJ
Cancer Res; 1990 Sep; 50(17):5587-93. PubMed ID: 2201439
[TBL] [Abstract][Full Text] [Related]
4. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
[TBL] [Abstract][Full Text] [Related]
5. Silencing of N-Ras gene expression using shRNA decreases transformation efficiency and tumor growth in transformed cells induced by anti-BPDE.
Zhou L; Jiang Y; Tan A; Greenlee AR; Shen Y; Liu L; Yang Q
Toxicol Sci; 2008 Oct; 105(2):286-94. PubMed ID: 18567617
[TBL] [Abstract][Full Text] [Related]
6. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
7. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
8. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
9. Synovial fibroblast-like cell transfection with the SV40 large T antigen induces a transformed phenotype and permits transient tumor formation in immunodeficient mice.
Lemaire R; Flipo RM; Monté D; Dupressoir T; Duquesnoy B; Cesbron JY; Janin A; Capron A; Lafyatis R
J Rheumatol; 1994 Aug; 21(8):1409-19. PubMed ID: 7983639
[TBL] [Abstract][Full Text] [Related]
10. Ha-Ras-1 oncogene dosage differentially affects Balb/3T3 cells' growth factor requirement and tumorigenicity.
Kovary K; Armelin MC; Armelin HA
Oncogene Res; 1989; 4(1):55-64. PubMed ID: 2654813
[TBL] [Abstract][Full Text] [Related]
11. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
Radinsky R; Kraemer PM; Proffitt MR; Culp LA
Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
[TBL] [Abstract][Full Text] [Related]
12. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
13. CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene.
Kogerman P; Sy MS; Culp LA
J Cell Physiol; 1996 Nov; 169(2):341-9. PubMed ID: 8908201
[TBL] [Abstract][Full Text] [Related]
14. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
15. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
Kivinen L; Pitkänen K; Laiho M
Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes.
Arends MJ; McGregor AH; Wyllie AH
Am J Pathol; 1994 May; 144(5):1045-57. PubMed ID: 8178928
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
[TBL] [Abstract][Full Text] [Related]
18. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
[TBL] [Abstract][Full Text] [Related]
20. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
